Hughes syndrome and Multiple sclerosis

Abstract

Multiple sclerosis (MS) and antiphospholipid syndrome (APS) share common clinical, laboratory and radiological features. We reviewed all the English papers on MS and APS published in the literature from 1965 to 2014 using PubMed and Google Scholar. We found that APS can mimic antiphospholipid antibodies (aPL)-positive MS in many ways in its clinical presentation. Nevertheless, APS diagnosis, clinical manifestations and management differ from those of MS. aPL were found in MS patients with titers ranging from 2% to 88%. The distribution and volume of lesions on magnetic resonance imaging (MRI) may help to differentiate MS from primary APS. In addition, atypical MS presentation can guide physicians toward an alternative diagnosis, especially when features of thrombosis and/or history of connective tissue disease are present. In that case, an anticoagulation trial could be worthwhile. © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Description

Keywords

Antiphospholipid antibodies (apl), Antiphospholipid syndrome (aps), Hughes syndrome, Multiple sclerosis (ms), Antibodies, antiphospholipid, Anticoagulants, Antiphospholipid syndrome, Diagnosis, differential, Humans, Magnetic resonance imaging, Multiple sclerosis, Thrombosis, Acetylsalicylic acid, Beta1 interferon, Corticosteroid, Immunoglobulin, Phospholipid antibody, Anticoagulant agent, Antibody titer, Anticoagulant therapy, Clinical feature, Corticosteroid therapy, Human, Nuclear magnetic resonance imaging, Patient care, Priority journal, Review, Differential diagnosis, Immunology, Pathophysiology

Citation

Endorsement

Review

Supplemented By

Referenced By